HOXB4 and cervical cancer: These data confirmed that HOXB4 inhibited the activity of the Wnt/β-catenin signaling pathway by downregulating β-catenin expression; however, the Wnt/β-catenin signaling pathway had no effect on HOXB4 in cervical cancer cells.